Literature DB >> 15760587

Recent advances in juvenile dermatomyositis.

Ann M Reed1, Thomas Mason.   

Abstract

This paper reviews the knowledge we continue to gain in the areas of pathogenesis, evaluation of disease activity, and interventional strategies with regards to idiopathic inflammatory myositis. Potential new diagnostic criteria incorporate the use of magnetic resonance imaging and other imaging modalities along with the use of muscle biopsy pathologic features including that of immunologic markers. Specifically, this criterion reflects the upregulation of major histocompatibility complex molecules on muscle tissue during acute inflammation.

Entities:  

Mesh:

Year:  2005        PMID: 15760587     DOI: 10.1007/s11926-005-0060-5

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  13 in total

1.  Association among somatic HPRT mutant frequency, peripheral blood T-lymphocyte clonality, and serologic parameters of disease activity in children with juvenile onset dermatomyositis.

Authors:  L S Abramson; R J Albertini; L M Pachman; B A Finette
Journal:  Clin Immunol       Date:  1999-04       Impact factor: 3.969

Review 2.  International consensus on preliminary definitions of improvement in adult and juvenile myositis.

Authors:  Lisa G Rider; Edward H Giannini; Hermine I Brunner; Nicola Ruperto; Laura James-Newton; Ann M Reed; Peter A Lachenbruch; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2004-07

3.  Oligoclonal expansion of circulating and tissue-infiltrating CD8+ T cells with killer/effector phenotypes in juvenile dermatomyositis syndrome.

Authors:  K Mizuno; A Yachie; S Nagaoki; H Wada; K Okada; M Kawachi; T Toma; A Konno; K Ohta; Y Kasahara; S Koizumi
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

4.  Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies.

Authors:  Adam M Huber; Brian M Feldman; Robert M Rennebohm; Jeanne E Hicks; Carol B Lindsley; Maria D Perez; Lawrence S Zemel; Carol A Wallace; Susan H Ballinger; Murray H Passo; Ann M Reed; Ronald M Summers; Patience H White; Ildy M Katona; Frederick W Miller; Peter A Lachenbruch; Lisa G Rider
Journal:  Arthritis Rheum       Date:  2004-05

5.  Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety.

Authors:  P Riley; S M Maillard; L R Wedderburn; P Woo; K J Murray; C A Pilkington
Journal:  Rheumatology (Oxford)       Date:  2004-01-13       Impact factor: 7.580

6.  Expression of class I and class II MHC antigens in neuromuscular diseases.

Authors:  R M McDouall; M J Dunn; V Dubowitz
Journal:  J Neurol Sci       Date:  1989-02       Impact factor: 3.181

7.  MHC Class I overexpression on muscles in early juvenile dermatomyositis.

Authors:  Charles K C Li; Hemlata Varsani; Janice L Holton; Bin Gao; Patricia Woo; Lucy R Wedderburn
Journal:  J Rheumatol       Date:  2004-03       Impact factor: 4.666

8.  Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis?

Authors:  Ann M Reed; Kelly McNallan; Peter Wettstein; Richard Vehe; Carole Ober
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

9.  Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.

Authors:  S M Maillard; R Jones; C Owens; C Pilkington; P Woo; L R Wedderburn; K J Murray
Journal:  Rheumatology (Oxford)       Date:  2004-02-24       Impact factor: 7.580

10.  Fitness as a determinant of the oxygen uptake/work rate slope in healthy children and children with inflammatory myopathy.

Authors:  Bart E Drinkard; Jeanne Hicks; Jerome Danoff; Lisa G Rider
Journal:  Can J Appl Physiol       Date:  2003-12
View more
  1 in total

Review 1.  [Connective tissue diseases in childhood].

Authors:  K Gensch; S Gudowius; T Niehues; A Kuhn
Journal:  Hautarzt       Date:  2005-10       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.